The future of ORL-HNS and associated specialties series: The future of radiotherapy and chemotherapy in head and neck cancer

Journal of Laryngology and Otology

Volumn 114, Issue 6, 2000, Pages 411-413

  Bridgewater, Caroline H ^a   Spittle, Margaret F ^a  

^a MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

Brachytherapy; Chemotherapy; Cisplatin; Paclitaxel; Radiosurgery; Radiotherapy

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL; GEMCITABINE; PACLITAXEL;

CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFICACY; HEAD AND NECK CANCER; HUMAN; MULTIMODALITY CANCER THERAPY; RECURRENT CANCER; REVIEW; TREATMENT OUTCOME; ARTICLE; BRACHYTHERAPY; FORECASTING; HEAD AND NECK TUMOR; METHODOLOGY; RADIOSURGERY; TUMOR RECURRENCE;

BRACHYTHERAPY; FORECASTING; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM RECURRENCE, LOCAL; RADIOSURGERY;

EID: 0034204252     PISSN: 00222151     EISSN: None     Source Type: Journal    
DOI: 10.1258/0022215001905805     Document Type: Review

References (15)

1. Vikram B, Strong WE, Shah JP, Spiro R. Second malignant neoplasms in patients successfully treated with multimodality treatment for advanced head and neck cancer. Head Neck Surg 1984;6:734-7
2. Thornton AF, Laramore GE. Technical advances in radiotherapy of head and neck tumours. Hematol Oncol Clin North Am 1999;13:811-23
3. Loeffler JS, Alexander E 3rd, Siddon RL, Saunders WM, Coleman CN, Winston KR. Stereotactic radiosurgery for intracranial arteriovenous malformations using a standard linear accelerator. Int J Radiat Oncol Biol Phys 1989;17:673-7
4. Saunders M, Dische S, Barrett A, Harvey A, Gibson D, Parmar M, on behalf of the CHART Steering Committee. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: a randomised muticentre trial. Lancet 1997;350:161-5
5. Horiot JC, Bontempts P, Begg AC, LeFur R, Van Den Boaert W, Bella M, et al. Radiotherapie hyperfractione et accelerée dans les cancers de la tet et du cou: resultats des essais de l'EORTC et impact sur la pratique clinique. Bull Cancer Radiother 1996;83:314-20
6. Adelstein DJ. Induction chemotherapy in head and neck cancer. Hematol Oncol Clin North Am 1999;13:689-98
7. Ensley JF, Maciorowski Z. Clinical applications of DNA content parameters in patients with squamous cell carcinomas of the head and neck. Semin Oncol 1994;21:330-9
8. Brown AW Jr., Blom J, Butler WM, Garcia-Guerrero G, Richardson MF, Henderson RL. Combination chemotherapy with vinhlastine, bleomycin. and cis-diaminedichlor-oplatinum (II) in squamous cell carcinoma of the head and neck. Cancer 1980;45:2830-5
9. Randolph VL, Vallejo A, Spiro RH, Shah J, Strong WE, Huvos AG, et al. Combination therapy of advanced head and neck cancer. Induction of remissions with diaminedichloroplatinum (II), bleomycin and radiation therapy. Cancer 1978;41:460-7
10. Ensley JF, Jacobs JR, Weaver, A, Kinzie J, Crissman J, Kish JA. et al. Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck. Cancer 1984;54:811-4
11. Calais G, Alfonsi M, Bardet E, Sire C, Germain T, Bergerot P, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Int 1999;91:2081-6
12. Bourhis J, Pignon JP, Designe L. Meta-analysis of chemotherapy in head and neck cancer(MACH-NC): (1) Loco-regional treatment vs same treatment + chemotherapy [abstract]. Proc Am Soc Ciln Oncol 1998;17:386a
13. Posner M, Dreyfuss A, Clark J. Docetaxel for advanced incurable squamous cell carcinoma of the head and neck. Proc Am Soc Clin Oncol 1996;15:311
14. Clavel M, Vermerken JB, Cognetti F, Cappelaere P, de Mulder PH, Schornageln JH, et al. Randomised comparison of cisplatin methotrexate. bleomycin and vincristine (CABO) vs cisplatin and 5-fluorouracil (CF) vs cisplatin in recurrent or metastatic squamous cell carcinoma of the head and neck: a phase II study of the EORTC head and and Neck Cancer Cooperative Group. Ann Oncol 1994;5:521-6
15. Fliss MS, Usadel H, Caballero O, Wu L, Buta MR, Eleff SM. et al. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 2000;287:2017-9